According to a recent LinkedIn post from Twentyeight Health, the company is partnering with ŌURA to link hormonal health insights from wearable data with virtual clinical care. The post describes new ŌURA features focused on hormonal birth control and menopause, which aim to show how hormonal changes manifest in sleep, recovery, and symptoms over time.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post indicates that Twentyeight Health will enable members to connect cycle, sleep, and symptom data directly with licensed providers for more personalized birth control counseling and care decisions. The company highlights its Complete Care model, which the post says includes insurance-enabled care, prescription management, and ongoing support to help users move from data insights to actionable treatment.
For investors, this partnership suggests an effort by Twentyeight Health to deepen integration with a leading consumer wearable platform and strengthen its position in data-driven women’s health. If successfully adopted, the approach could enhance user engagement, support higher retention, and potentially expand the addressable market for virtual reproductive and hormonal care services.
The collaboration also points to continued convergence between digital therapeutics, remote care, and consumer health devices, an area attracting growing payer and partner interest. While the post does not provide financial terms or adoption metrics, the strategic alignment with ŌURA’s user base may provide Twentyeight Health with a differentiated offering in a competitive telehealth and femtech landscape.